Is the central complement component C3 altered in the synergy of HIV infection and preeclampsia?
Objective: In light of complement activation in preeclampsia and HIV infection, this study evaluates the concentration of complement component 3 (C3) in HIV-associated preeclampsia. Method: The study population (n = 76) was equally stratified by pregnancy type (normotensive pregnant and preeclampsia...
Main Authors: | Mikyle David, Shoohana Singh, Thajasvarie Naicker |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | European Journal of Obstetrics & Gynecology and Reproductive Biology: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590161323000820 |
Similar Items
-
The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia
by: Mikyle David, et al.
Published: (2023-07-01) -
HIV Associated Preeclampsia: A Multifactorial Appraisal
by: Thajasvarie Naicker, et al.
Published: (2021-08-01) -
THE ROLE OF HUMAN COMPLEMENT PROTEIN FACTOR B AND FACTORP/PROPERDIN IN HIV-ASSOCIATED PRE-ECLAMPSIA
by: Phumelele Kikine, et al.
Published: (2022-01-01) -
Dysregulation of circulating sTie2 and sHER2 in HIV-infected women with preeclampsia
by: Mduduzi Mazibuko, et al.
Published: (2019-04-01) -
Role of angiopoietin-2, endoglin, and placental growth factor in HIV-associated preeclampsia
by: Nokuzola Mbhele, et al.
Published: (2017-07-01)